Skip to content

Sunday, August 1, 2021

Latest:

FROM THE LABS: New COVID-19 vaccine formulation produces effective vaccine candidate
Turning the molecular clock back on halts neuroblastoma tumor growth
Progress Notes MS1/MS4 profile: Will Frankel
Communications and public health: An interview with Monisha Arya, M.D., M.P.H
Naturally occurring antibodies recognize many different noroviruses

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CDKN2A gene

From The Labs

Exploring the risk of ALL in children with Down syndrome

September 24, 2019September 24, 2019 Ana Rodríguez 0 Comments Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

From the Labs Image of the Month

From the Labs features an image of autofluorescence of pollen from Lilium orientalis "Stargazer." Image courtesy of J. Kirk/ OiVM.